Home524715 • BOM
Follow
Sun Pharmaceutical Industries Ltd
Previous close
₹1,536.95
Day range
₹1,506.80 - ₹1,549.75
Year range
₹922.55 - ₹1,638.70
Market cap
3.66T INR
Avg Volume
142.30K
P/E ratio
41.06
Dividend yield
0.82%
Primary exchange
NSE
In the news
Financials
Income Statement
Revenue
Net income
| (INR) | Dec 2023info | Y/Y change |
|---|---|---|
Revenue | 123.81B | 10.14% |
Operating expense | 69.14B | 13.52% |
Net income | 25.24B | 16.52% |
Net profit margin | 20.38 | 5.76% |
Earnings per share | 10.77 | 19.64% |
EBITDA | 33.17B | 16.52% |
Effective tax rate | 14.45% | — |
Balance Sheet
Total assets
Total liabilities
| (INR) | Dec 2023info | Y/Y change |
|---|---|---|
Cash and short-term investments | 148.33B | 7.22% |
Total assets | — | — |
Total liabilities | — | — |
Total equity | 631.97B | — |
Shares outstanding | 2.40B | — |
Price to book | 6.16 | — |
Return on assets | — | — |
Return on capital | 10.48% | — |
Cash Flow
Net change in cash
| (INR) | Dec 2023info | Y/Y change |
|---|---|---|
Net income | 25.24B | 16.52% |
Cash from operations | — | — |
Cash from investing | — | — |
Cash from financing | — | — |
Net change in cash | — | — |
Free cash flow | — | — |
About
Sun Pharmaceutical Industries Limited is an Indian multinational pharmaceutical company headquartered in Mumbai, that manufactures and sells pharmaceutical formulations and active pharmaceutical ingredients in more than 100 countries across the globe. It is the largest pharmaceutical company in India and the fourth largest specialty generic pharmaceutical company in the world. The products cater to a vast range of therapeutic segments covering psychiatry, anti-infectives, neurology, cardiology, diabetology, gastroenterology, ophthalmology, nephrology, urology, dermatology, gynecology, respiratory, oncology, dental and nutritionals. Wikipedia
Founded
1983
Headquarters
Website
Employees
41,000
